Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,686 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 564 of 641 · 7,686 filings

  • Coca-Cola Consolidated (COKE) FY2024 10-K risk factors
    19 risks

    The company relies heavily on its operational agreements with The Coca-Cola Company for manufacturing and distribution rights. High debt levels, large acquisition-related contingent liabilities, and concentrated CEO voting control dominate the risk profile.

    Filed Feb 20, 2025
  • Camden Property Trust (CPT) FY2024 10-K risk factors
    24 risks

    Capital market volatility and economic conditions impact apartment rental rates and occupancy levels.

    Filed Feb 20, 2025
  • Cheniere Energy Partners (CQP) FY2024 10-K risk factors
    30 risks

    Liquidity relies heavily on capital availability and debt covenants restricting distributions and investments. Operations face severe hazards from catastrophic weather and natural gas supply disruptions. Complex MLP tax structures create continuous IRS and unitholder tax compliance risks.

    Filed Feb 20, 2025
  • Cra International (CRAI) FY2024 10-K risk factors
    24 risks

    Professional services rely heavily on key consultants and non-employee experts. Revenue concentration and client dispute terminations threaten performance. International operations face currency and regulatory volatility.

    Filed Feb 20, 2025
  • Costar Group (CSGP) FY2024 10-K risk factors
    Risk factors section under review

    CoStar depends on real estate advertising, marketplace traffic, and customer demand across its property platforms.

    Filed Feb 20, 2025
  • Qwest (CTGG) FY2024 10-K risk factors
    40 risks

    Declining revenues and high debt levels dominate Qwest Corp's risk profile, alongside ongoing network transformations and legacy copper infrastructure liabilities.

    Filed Feb 20, 2025
  • CTO Realty Growth (CTO) FY2024 10-K risk factors
    91 risks

    The company's risks are heavily concentrated on commercial real estate ownership, retail tenant performance, and e-commerce competition. Significant risk exposure stems from its relationship with PINE, including management fees and equity investments. Real estate debt investments, commercial loans, construction financing, and leverage levels significantly impact financial stability.

    Filed Feb 20, 2025
  • Crane NXT (CXT) FY2024 10-K risk factors
    15 risks

    Demand volatility stems from global trends away from cash and increased banknote durability. Non-U.S. sales accounted for 48% of consolidated amounts in 2024. Goodwill and intangible assets totaled $1,375.9 million, representing 58% of total assets. Separation-related risks involve IRS rulings and agreements with Crane Company.

    Filed Feb 20, 2025
  • DANA (DAN) FY2024 10-K risk factors
    32 risks

    Dana faces significant customer concentration, with its top ten customers generating 58 percent of sales in 2024. The company is managing strategic restructuring, including cost reduction actions announced in November 2024 and a sale process for its Off-Highway business. Operations are heavily exposed to international markets, with 55 percent of sales originating outside the United States. The business is navigating the complex technological transition from internal combustion engines to electric and alternate fuel vehicles.

    Filed Feb 20, 2025
  • Dime Commercial Bancshares (DCOM) FY2024 10-K risk factors
    23 risks

    Dime Commercial Bancshares is heavily exposed to commercial and multi-family real estate lending in Greater Long Island and Manhattan. The bank faces intense competition, interest rate sensitivity, and stringent regulatory oversight from federal and state agencies.

    Filed Feb 20, 2025
  • Quest Diagnostics (DGX) FY2024 10-K risk factors
    37 risks

    Quest Diagnostics faces significant risks from evolving value-based reimbursement models and government and third-party payer pricing pressures. The company carries $6.2 billion in debt and operates in a highly competitive, regulated clinical testing market. Cybersecurity threats, AI adoption challenges, and labor constraints among specialized personnel threaten operations.

    Filed Feb 20, 2025
  • Danaher (DHR) FY2024 10-K risk factors
    41 risks

    Danaher faces significant risks from global healthcare cost pressures and government reimbursement reliance in its served markets.

    Filed Feb 20, 2025

Companies covered

4,011 companies

371 more under A